Boomerang Ventures

Boomerang Ventures
Menu
STUDIO APPLICATION
FUND APPLICATION
BOOMERANG

NEWS

Keep up with Boomerang Ventures as we launch new companies, engage new investors, close fundraising rounds, share industry insights, and achieve other significant milestones in the life of our team and portfolio companies.
Learn More

Back to News Page

Press Release: Boomerang Ventures Makes Seed-Stage Investment in SynchNeuro to Advance Brain-Based Non-Invasive Glucose Monitoring Technology
Press Releases

Boomerang Ventures Makes Seed-Stage Investment in SynchNeuro to Advance Brain-Based Non-Invasive Glucose Monitoring Technology

Boomerang Ventures has announced a seed-stage investment in SynchNeuro, a pioneering neurotechnology company developing the world’s first brain-based, non-invasive continuous glucose monitor. The partnership accelerates SynchNeuro’s mission to revolutionize cardiometabolic health through EEG-based technology that interprets brain signals to track blood glucose and other vital metrics in real time. This innovative approach aims to make proactive, pain-free, and affordable glucose monitoring accessible to millions.

Read More »
11/12/2025
In the News
In The news

IBJ News: FDA Upheaval Worries Local Companies

Source: Indianapolis Business Journal
The Trump administration’s decision to cut 3,500 FDA jobs is stirring concern among Indianapolis-based companies that rely on the agency for product approvals and regulatory clarity. While federal officials say inspections and reviews will be unaffected, local medical device and software firms report anxiety over potential delays, investor hesitation, and confusion about shifting FDA protocols—especially around AI-enabled technologies. Health tech leaders from Greenlight Guru, Boomerang Ventures, and Eagle Creek Consultants weigh in on the ripple effects of the shakeup.

Read More »
04/11/2025

Back to News Page

Boomerang Ventures
Loading...